Vitamin d measurement method and measurement kit
US-2015355202-A1 · Dec 10, 2015 · US
US9234012B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9234012-B2 |
| Application number | US-201313874437-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 30, 2013 |
| Priority date | Apr 30, 2012 |
| Publication date | Jan 12, 2016 |
| Grant date | Jan 12, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a cobalamin acquisition protein, compositions containing the cobalamin acquisition protein, and the use of such compositions.
Opening claim text (preview).
What is claimed is: 1. A recombinant microorganism comprising a heterologous nucleic acid encoding a protein comprising an amino acid sequence having at least 90% identity with SEQ ID NO: 2, wherein the nucleic acid is disposed within a recombinant expression vector construct and can be expressed to produce a protein that binds Vitamin B 12 . 2. The recombinant microorganism of claim 1 , wherein the nucleic acid is operatively associated with an inducible promoter. 3. The recombinant microorganism of claim 1 , wherein the nucleic acid is operatively associated with a constitutive promoter. 4. The recombinant microorganism of claim 1 , wherein the microorganism, under the same environmental conditions, (i) is capable of binding more vitamin B 12 over a preselected period of time than an organism without the nucleic acid, (ii) is capable of taking up more Vitamin B 12 over a preselected period of time than an organism without the nucleic acid, (iii) is capable of growing faster over a preselected period of time than an organism without the nucleic acid, or a combination thereof. 5. The recombinant microorganism of claim 1 , wherein the microorganism is an algae. 6. A viable culture comprising the recombinant microorganism of claim 1 . 7. A method of growing the culture of claim 6 under conditions that permit the growth of the recombinant microorganism.
involving vitamins {or their receptors} · CPC title
from algae · CPC title
from invertebrates · CPC title
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)} · CPC title
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.